Navigation Links
Newborn screening can cause unnecessary parental stress

Virtually all babies in the U.S. have their heels pricked soon after birth to get a blood sample for genetic testing. These "heel stick" tests identify rare metabolic disorders before they cause irreversible damage, but as more disorders are added to the screening ?many states now test for 30 or more ?false-positive results are on the rise. In the June issue of Pediatrics, researchers from Children's Hospital Boston report that false-positive results cause considerable parental stress, even when the baby proves negative on retesting, and that the stress could be alleviated by better education for parents and pediatricians.

Psychologist Susan Waisbren, PhD and Elizabeth Gurian, MS in Children's Division of Genetics interviewed 173 families who had received false-positive screening results and a comparison group of 67 families with normal newborn screening results.

Although mothers in the false-positive group were interviewed at least six months after their child's diagnosis had been ruled out, they reported more worry about their child's future and rated themselves less healthy than mothers in the comparison group. Fifteen percent said their child needed extra parental care, versus 3 percent of mothers in the comparison group. After adjustment for socioeconomic factors, both mothers and fathers in the false-positive group had higher scores on the standardized Parenting Stress Index (PSI); 11 percent of mothers (versus no mothers in the comparison group) scored in the clinical range, in which treatment might be prescribed.

Waisbren and Gurian also found that false-positive tests affected the parent-child relationship: parents in the false-positive group scored more highly on two subscales of the PSI: a Parent-Child Dysfunctional Interaction scale and a Difficult Child scale. (The first asks parents to rate their agreement with statements like "I expected to have closer and warmer feelings for my child, and this bothers me"; the second has sta tements such as "My child makes more demands on me than most children.")

Waisbren believes a positive test result can increase expectations of illness even when it is later found to be in error. "We're not sure why ?maybe it feeds into a general nervousness as new parents," she speculates. "But our results also show that parental stress was greater when families didn't have adequate information and understanding."

Two-thirds of parents with false-positive results did not correctly understand why their child was called back for a repeat test, the study found. Mothers who knew the correct reason had reduced stress. (This was not true for fathers, however.)

Other findings:

  • Some parents had to wait as long as a month to get the result of the second test, and 26 percent voiced concerns about the length of time before a diagnosis was ruled out.
  • Half of all parents in the false-positive group said they hadn't been told, or didn't remember being told, that the diagnosis had been ruled out.
  • Of these, 22 percent said they were told they wouldn't be notified unless a problem was found, and 24 percent were required to ask their pediatrician for the test results. "A few parents didn't even know they'd had a repeat test," Waisbren says.
  • Sixty-one percent of parents felt a need for more information about newborn screening and the test result.

The researchers suggest that improved and better-timed education may reduce parental stress related to newborn screening. "There needs to be a specific communication plan for informing parents at every step," Gurian says. "Currently, pediatricians are the primary distributors of this information, but some pediatricians don't feel knowledgeable enough about these rare metabolic disorders to explain a positive test to a parent. It would be good to begin involving obstetricians and to begin educating parents about newborn screening during the prenatal period."

The study was funded by the Maternal and Child Health Bureau of the U.S. Health Resources and Services Administration and the Ethical, Legal and Social Implications (ELSI) division of the Human Genome Project, National Institutes of Health.

According to the CDC, over 4 million babies born in the U.S. each year undergo screening for biochemical genetic disorders, with severe disorders detected in about 3,000. One recent study suggests that there are at least 12 false-positive results for every true case diagnosed*; another puts the ratio at more than 50:1.**


'"/>

Source:Children's Hospital Boston


Related biology news :

1. Opiates Better Than Sedatives For Treating Newborns In Withdrawal
2. Newborn brains grow vision and movement regions first
3. Newborn neurons like to hang with the in crowd
4. MetaChip provides quick, efficient toxicity screening of potential drugs
5. Boosting HIV screening can increase survival and is cost effective
6. Researchers develop assay that could be applied to drug screening
7. NIH creates nationwide network of molecular libraries screening centers
8. UT Southwestern researchers develop screening test for cells that activate immune system
9. Handling HPV vaccines and screening: The views of 100 authors
10. Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds
11. Dysentery uses sword and shield to cause infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2016)... Fla., Nov. 14, 2016  xG Technology, Inc. ("xG" ... providing critical wireless communications for use in challenging operating ... September 30, 2016. Management will hold a conference call ... 5:00 p.m. Eastern Time (details below). Key ... a $16 million binding agreement to acquire Vislink Communication ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... Collins, Colorado (PRWEB) , ... December 06, 2016 ... ... of dynamic aqueous plasma technology platforms, announced today that the company has engaged ... Master Research and Development Agreement (MRDA) with the CSU Office of the Vice ...
(Date:12/6/2016)... SAN DIEGO , Dec. 6, 2016 /PRNewswire/ ... Santosh Kesari , MD, PhD, FANA, FAAN to ... experience in neurology and clinical trials to assist the ... treatment of stroke. The AmnioStem product is a universal donor ... shown therapeutic activity in animal models of stroke 1 ...
(Date:12/6/2016)... , Dec. 6, 2016  The Texas ... Society of Australia (HISA) today announced the establishment ... exchange program between Australia and ... the world. HISA and the Texas ... a program to create a global health innovation ecosystem ...
(Date:12/5/2016)... , Dec. 5, 2016 Axovant Sciences ... biopharmaceutical company focused on the treatment of dementia, today ... for the treatment of Alzheimer,s disease will be presented ... Meeting on Friday, December 9, 2016 in ... show results of both simple and complex measures of ...
Breaking Biology Technology: